Profile for GlobeImmune, Inc. (GBIM)
« Back to company indexGBIM Chatter Timeline
Stock Ticker for GBIM
Most Active Tweeters for GBIM
| User | Tweets |
|---|---|
| @Zoomlik1 | 5 |
| @CaesarBiotech | 5 |
Recent Tweets for GBIM
 |
@CaesarBiotech RT @Zoomlik1: $gbim 6301 trial amend requires actigraph wrist-worn for responders and non resp .. to show clinical benefits ..accel approv… July 20th 2017, 10:07am |
 |
@Zoomlik1 $gbim 6301 trial amend requires actigraph wrist-worn for responders and non resp .. to show clinical benefits ..accel approval ?? July 19th 2017, 1:07pm |
|
@Zoomlik1 $gbim .. Only manufacturing job at Nant website is in Louisville, CO $gbim location July 19th 2017, 1:07pm |
|
@CaesarBiotech It seems like $GBIM will take a major place and be in charge of development and production of vaccine agents of all Nant Cancer Vaccines $NK July 19th 2017, 11:07am |
|
@CaesarBiotech Again and again a new job offer for $GBIM https://t.co/csxrdlLXvK 6 new job postions since $NK deal and no SP revaluation. July 19th 2017, 11:07am |
|
@Zoomlik1 $gbim 6301 / secondary updated .. refers to responders and non-responders July 18th 2017, 4:07pm |
|
@CaesarBiotech RT @CaesarBiotech: $GBIM really ? Since $NK deal 1. Assets involved in 13 clin. trial (vs 2) 2. Restructuring already acting (5 new jobs) 3… July 18th 2017, 1:07pm |
|
@CaesarBiotech RT @Zoomlik1: $gbim .. interesting that job is posted by nantworks for Louisville location .. $nk https://t.co/6OUgqAURkC July 18th 2017, 1:07pm |
|
@Zoomlik1 $gbim .. interesting that job is posted by nantworks for Louisville location .. $nk https://t.co/6OUgqAURkC July 18th 2017, 11:07am |
|
@Zoomlik1 @NantKwest @DrPatSoonShiong $nk + IL-15 / Altor + KRAS & Brachyury / $gbim + MUC1 / Etubic + CEA / Etubics & g… https://t.co/QKht0SA9QG July 16th 2017, 3:07pm |
|
@CaesarBiotech RT @Zoomlik1: $gbim Employee page is new .. was set up last week https://t.co/GMIn3Re2ks July 11th 2017, 2:07pm |
|
@Zoomlik1 $gbim Employee page is new .. was set up last week https://t.co/GMIn3Re2ks July 10th 2017, 8:07pm |
|
@CaesarBiotech RT @Zoomlik1: $gbim .. Hiring for setting up manufacturing continues .. two more positions https://t.co/oCkPoSfba1 July 5th 2017, 2:07pm |
|
@CaesarBiotech RT @Zoomlik1: $gbim .. Restsrt manufacturing continues https://t.co/yVavj6oL75 July 5th 2017, 2:07pm |
|
@Zoomlik1 $gbim .. Restsrt manufacturing continues https://t.co/yVavj6oL75 July 5th 2017, 1:07pm |
 |
@jwbartelt RT @Zoomlik1: $gbim unique contribution to nantcell vaccine are KRAS, brachyury (Etubics still not ready yet) and a different MoA than Etub… June 25th 2017, 5:06pm |
|
@CaesarBiotech @aschwartzphd 300M$ for Altor and it's IL-15 superagonist. How much for $GBIM tarmogen vaccines which are in ~ all NantCancerVaccines ? ... June 25th 2017, 1:06pm |
|
@CaesarBiotech Relevant reference for helping to value $GBIM Tarmogen vaccines which (as ALT-803) are essential part of NantCancerVaccines. GBIM mkcap<10M$ June 25th 2017, 1:06pm |
|
@CaesarBiotech @Zoomlik1 As I said you, Altor merger with $gbim was always my first feeling regarding synergies and PSS plan for n… https://t.co/wZhFtvPb8l June 23rd 2017, 10:06pm |
|
@Zoomlik1 $gbim Logical 1- PSS buys Altor 2- merges Altor with gbim 3- Relists Newco, 4- sells 20% to public at $500M valuation June 23rd 2017, 10:06pm |
|
@CaesarBiotech @sommerjo Gottlieb’s FDA GI-6301 $GBIM $CELG "Targeted drugs designed to treat rare diseases and other unmet needs" https://t.co/9oTpbJoa38 June 22nd 2017, 12:06am |
|
@CaesarBiotech Gottlieb’s FDA "targeted drugs designed to treat rare diseases and other unmet needs are one area of focus" $GBIM $CELG GI-6301 #chordoma June 22nd 2017, 12:06am |
 |
@bullriders1 $GBIM +43% $0.50 penny-pumper June 11th 2017, 6:06pm |
|
@jwbartelt @aschwartzphd $gbim PR likely imminent June 6th 2017, 10:06am |
|
@Zoomlik1 RT @aschwartzphd: Combo pembrolizumab anti-PD-1 $MRK with $GBIM vaccine GI-6207 for medullary thyroid Ca is now recruiting patients. https:… June 1st 2017, 12:06pm |
 |
@aschwartzphd Combo pembrolizumab anti-PD-1 $MRK with $GBIM vaccine GI-6207 for medullary thyroid Ca is now recruiting patients. https://t.co/u3wl7DfDld June 1st 2017, 12:06pm |
|
@toronto_orlando @aschwartzphd Yes I just complained that I want an update however, I have faith in them at $gbim and I am excited t… https://t.co/Hh9Y2I6B09 May 31st 2017, 9:05am |
|
@CaesarBiotech Discretly, $GBIM is now involved in NINE cancer clinical trials and market cap is still under 10M$ : Overreactions are always corrected May 31st 2017, 6:05am |
|
@CaesarBiotech @aschwartzphd $GBIM involved in 9 ph2 cancer trials and mktcap<10M$ Let's them finish to buy all the shares and aft… https://t.co/0zaxsCzgyC May 30th 2017, 11:05pm |
|
@aschwartzphd @CaesarBiotech Def a ? Of mine but unclear since they own 70% of $gbim. May 25th 2017, 11:05am |
|
@Zoomlik1 @aschwartzphd As always excellent find Tony .. our little $gbim will fly soon to a new orbit .. restart manufacturing !!! May 25th 2017, 11:05am |
 |
@pharma_sector #GlobeImmune Globeimmune Inc Financial and Strategic SWOT Analysis Review Updated 15052017... Read more: https://t.co/rv060s5Dls $GBIM May 17th 2017, 5:05am |
 |
@biotech_sector #GlobeImmune Globeimmune Inc Financial and Strategic SWOT Analysis Review Updated 15052017... Read more: https://t.co/evoBt1urBo $GBIM May 17th 2017, 5:05am |
 |
@bidaskclub #GlobeImmune $GBIM #BidaskScore is increased to #Held https://t.co/qv6i48HO55 May 15th 2017, 7:05pm |
|
@Zoomlik1 $gbim Out KRAS targeting in it https://t.co/xECwDqYOEq May 12th 2017, 7:05pm |
|
@CaesarBiotech RT @Zoomlik1: $nk $gbim Altor ALT-803 is a potent HIV-1 reversing agent and inhibits acute HIV-1 infection by activating NK cells Combo… May 10th 2017, 10:05am |
|
@Zoomlik1 $nk $gbim Altor ALT-803 is a potent HIV-1 reversing agent and inhibits acute HIV-1 infection by activating NK cells Combo W HBV coming May 10th 2017, 9:05am |
|
@jwbartelt RT @aschwartzphd: Is dead $GBIM coming back to life? Job openings (2) ? Recommissioning Ops? Yet the company refuses to disclose anything.… May 9th 2017, 10:05am |
|
@aschwartzphd Is dead $GBIM coming back to life? Job openings (2) ? Recommissioning Ops? Yet the company refuses to disclose anyt… https://t.co/exzOjVBWnm May 9th 2017, 9:05am |
|
@Zoomlik1 $gbim is now a cheap call option on 6301, 6207, 4000 pancreatic , and other trials .. few sellers left at this price .. May 4th 2017, 10:05am |
|
@Zoomlik1 @CaesarBiotech Partnership .. $gbim provides drug , Nantcell pays for dev .. we get % roy in sales Next trial will be breast cancer May 4th 2017, 8:05am |
 |
@Pwealth1971 $GBIM great potential once it bounces on lower Bollinger #pennystocks #supernovatraders #profit https://t.co/GMuxwhPX36 May 1st 2017, 1:05pm |
Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.